Home / Health / NHS Trial Boosts Organ Transplants by 19%
NHS Trial Boosts Organ Transplants by 19%
17 Mar
Summary
- New pilot scheme aims to increase organ transplants by 19%.
- Perfusion technique extends organ preservation time for assessment.
- Potential for 750 additional transplants annually in England.

A pioneering pilot scheme by NHS doctors in England is poised to dramatically enhance organ availability for transplants, with the potential to add 750 life-saving procedures annually. This initiative, currently active in several major hospitals, introduces perfusion techniques to extend the crucial preservation window for donor organs.
This extended time is vital for comprehensive assessments, a step often hampered by current time limitations. Doctors anticipate improved confidence in accepting organs for transplant, addressing a significant challenge that currently renders many organs unusable. The program aims to create a national network for organ reconditioning.
Perfusion involves circulating oxygenated fluids through organs to maintain function, allowing more time for necessary evaluations and for surgical teams to become available. This technique can extend the viability of organs, such as livers for 12-24 hours and hearts for up to eight hours, significantly improving transplant potential. It also aids in assessing organ functionality, particularly important as donor pools increasingly consist of older individuals.
NHS Blood and Transplant highlights an urgent need for such innovation, citing a record waiting list of over 8,000 people. The declining donor pool, due to longer lifespans and prevalent long-term health conditions, necessitates maximizing the use of available organs. The pilot seeks to standardize practices and create equitable access to these advanced preservation and assessment methods across the country.



